These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 6154517

  • 1. The role of biologic tumor markers in testicular cancer.
    Javadpour N.
    Cancer; 1980 Apr 15; 45(7 Suppl):1755-61. PubMed ID: 6154517
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Biologic tumor markers in management of testicular and bladder cancer.
    Javadpour N.
    Urology; 1978 Aug 15; 12(2):177-83. PubMed ID: 80871
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hormonal changes in urine and plasma by hormone-producing testicular tumors before and after treatment.
    Lindenmeyer D, Tomanek M, Körner F.
    Acta Endocrinol Suppl (Copenh); 1971 Aug 15; 152():26. PubMed ID: 5279415
    [No Abstract] [Full Text] [Related]

  • 7. Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors.
    Lange PH.
    Natl Cancer Inst Monogr; 1978 Dec 15; (49):215-7. PubMed ID: 86163
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current concepts in management of testicular tumor.
    Javadpour N.
    Urol Surv; 1978 Jun 15; 28(3):89-94. PubMed ID: 80873
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Prognostic and therapeutic implications of urinary gonadotropin levels in the management of testicular neoplasia.
    Wilson JM, Woodhead DM.
    J Urol; 1972 Nov 15; 108(5):754-6. PubMed ID: 4673245
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Biological markers for tumours of the testis. Their use in diagnosis, prognosis and follow-up in 200 cases (author's transl)].
    Bellet D, Caillaud JM, Droz JP, Delarue JC, Bohuon C.
    Nouv Presse Med; 1981 Nov 07; 10(40):3293-7. PubMed ID: 6170931
    [Abstract] [Full Text] [Related]

  • 15. [Determination of specific markers in the blood in tumors of the testis].
    Sakalo VS, Klimenko IA, Iaremko VN, Zaparin VK.
    Klin Khir (1962); 1990 Nov 07; (5):47-8. PubMed ID: 1697352
    [No Abstract] [Full Text] [Related]

  • 16. Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.
    Lange PH, McIntire KR, Waldmann TA, Hakala TR, Fraley EE.
    N Engl J Med; 1976 Nov 25; 295(22):1237-40. PubMed ID: 62281
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.